Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binapuxi granules for common cold (heat-type)
CTR20170994Phase 2Completed
- Sponsor
- Xinjiang Uygur Autonomous Region Institute of Drug Research
- Start
- Sep 2017
- Countries
- 1
01
Overview
A Phase 2 trial of binafuxi in nasopharyngitis, sponsored by Xinjiang Uygur Autonomous Region Institute of Drug Research. Started Sep 2017; status: completed.
02
Drugs
binafuxi
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20170994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170994.